Found 6 matching trials
Evaluation of UCPVax Vaccine +/- Pembrolizumab Combined With Standard Treatment as Adjuvant Therapy in Patients With Unmethylated MGMT Glioblastoma PHASE2 Glioblastomas (GBM) are the most frequent brain tumors and one of the most ...
Show More Learn More & Join Trial
Combination of UCPVax Vaccine and Atezolizumab for the Treatment of Human Papillomavirus Positive Cancers (VolATIL) PHASE2 70% all cases of cervical cancer, 95% of anal cancers and about 70% of orop...
Show More Learn More & Join Trial
Evaluation of the Interest to Combine a CD4 Th1-inducer Cancer Vaccine Derived From Telomerase and Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma PHASE2 The TERTIO trial will propose to determine the clinical interest and immuno...
Show More Learn More & Join Trial
Universal Cancer Peptide-based Vaccination in Metastatic NSCLC PHASE1 UCPVAx is a therapeutic vaccine based on the telomerase-derived UCP designe...
Show More Location
Centre Hospitalier Régional Universitaire de Besançon
Learn More & Join Trial
Anticancer Therapeutic Vaccination Using Telomerase-derived Universal Cancer Peptides in Glioblastoma PHASE2 Glioblastoma (GBM) is the most frequent primary brain tumor and the brain t...
Show More Learn More & Join Trial
Evaluation of UCPVax Plus Nivolumab as Second Line Therapy in Advanced Non Small Cell Lung Cancer PHASE2 Lung cancer is the most commonly diagnosed malignancy and the leading cause...
Show More Learn More & Join Trial